Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Accumulated Expenses (2010 - 2026)

Talphera (TLPH) posted Accumulated Expenses of $3.2 million for Q2 2026, up 28.72% on a QoQ basis from $2.4 million in Q1 2026, and up 175.2% year-over-year from $1.1 million in Q2 2025.

Analysis

Talphera (TLPH) Accumulated Expenses (2010 - 2026) Analysis & Trends

Talphera has reported Accumulated Expenses for 17 years, with the latest figure at $3.2 million in Q2 2026.

  • On a quarterly basis, Accumulated Expenses rose 175.2% year-over-year to $3.2 million in Q2 2026; TTM through Jun 2026 was $3.2 million, a 175.2% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 108.53% from the prior year.
  • Accumulated Expenses was $3.2 million for Q2 2026 at Talphera, up from $2.4 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $4.4 million in Q3 2022, with the low at $1.0 million in Q1 2025.
  • Average Accumulated Expenses over 5 years is $2.3 million, with a median of $1.9 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2026: Accumulated Expenses plunged 67.18% in 2023, then soared 175.2% in 2026.
  • Over 5 years, Accumulated Expenses stood at $2.5 million in 2022, then dropped by 3.4% to $2.4 million in 2023, then tumbled by 48.71% to $1.3 million in 2024, then surged by 108.53% to $2.6 million in 2025, then climbed by 20.5% to $3.2 million in 2026.
  • The last three Accumulated Expenses figures came in at $3.2 million (Q2 2026), $2.4 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Talphera 92.90 Mn 92.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.15 Mn
Mar 31, 2026 2.45 Mn
Dec 31, 2025 2.62 Mn
Sep 30, 2025 2.04 Mn
Jun 30, 2025 1.15 Mn
Mar 31, 2025 1.01 Mn
Dec 31, 2024 1.25 Mn
Sep 30, 2024 1.64 Mn
Jun 30, 2024 1.74 Mn
Mar 31, 2024 1.34 Mn
Dec 31, 2023 2.45 Mn
Sep 30, 2023 1.79 Mn
Jun 30, 2023 1.85 Mn
Mar 31, 2023 1.42 Mn
Dec 31, 2022 2.53 Mn
Sep 30, 2022 4.40 Mn
Jun 30, 2022 4.26 Mn
Mar 31, 2022 4.32 Mn
Dec 31, 2021 6.52 Mn
Sep 30, 2021 5.33 Mn